AbbVie is a U.S. publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. The new Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer.

NewsInvestor RelationsDividends

Score27,5
Updated09/29/2020FCF CAGR 5Y12,16%
SectorHealthcareDebt Coverage9,16
CodeNYSE:ABBVBVPS CAGR 5Y-217,97%
Moat2D/E Avg 5Y2,15
Cust. Base2EPS/Div. Avg 5Y1,34
Beta0,72FCF/Div. Avg 5Y2,09
Div. Streak8R&D Avg 5Y20,85%
Div. CAGR 5Y16,20%ROA Avg 5Y8,93%
Payout Avg 5Y76,81%ROE Avg 5Y39,84%
EPS CAGR 5Y11,02%ROIC Avg 5Y14,40%
(mil.)20152016201720182019
Revenues22 85925 63828 21632 75333 266
Earnings5 1445 9535 3095 6877 882
Equity3 9454 6365 097-8 446-8 172
Total Debt33 19936 84237 36840 31066 728
Earnings/Share3,133,633,303,665,28
Dividends/Share2,022,282,563,594,28
FCF/Share4,284,025,888,278,38
ROA9,70%9,01%7,50%9,58%8,84%
ROE130,39%128,41%104,16%-67,33%-96,45%
ROIC13,85%14,35%12,50%17,85%13,46%
FCF/Dividends2,121,762,302,301,96
EPS/Dividends1,551,591,291,021,23
Book Value/Share2,412,843,18-5,46-5,51
Debt/Share20,2822,5923,3126,0744,96
Payout Ratio %64,54%62,81%77,58%98,09%81,06%

See the Guidelines for more explanations.

See more Companies.

09/21/2020 – The dividend safety has been reviewed downward at only 3 as the fundamentals fail to show, for now, how ABBV could sustain such a high DGR. In anticipation, the 2020 payout ratio seems a bit too high.


© 2020 - Cyceon SARL, All rights reserved. Data is obtained from sources believed to be reliable and is provided without warranties of any kind. The publisher is not responsible for any errors or omissions herein. This publication does not constitute investment advice and is only for user's own, non-commercial, internal use. No part of it may be reproduced, resold, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product.